nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—respiratory system—chronic obstructive pulmonary disease	0.0143	0.209	CbGeAlD
Pamidronate—FDPS—connective tissue—chronic obstructive pulmonary disease	0.0126	0.184	CbGeAlD
Pamidronate—FDPS—bronchus—chronic obstructive pulmonary disease	0.0118	0.172	CbGeAlD
Pamidronate—FDPS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0115	0.168	CbGeAlD
Pamidronate—FDPS—trachea—chronic obstructive pulmonary disease	0.0106	0.155	CbGeAlD
Pamidronate—FDPS—lung—chronic obstructive pulmonary disease	0.00759	0.111	CbGeAlD
Pamidronate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00143	CcSEcCtD
Pamidronate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00143	CcSEcCtD
Pamidronate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00143	CcSEcCtD
Pamidronate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00143	CcSEcCtD
Pamidronate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00143	CcSEcCtD
Pamidronate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00143	CcSEcCtD
Pamidronate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00143	CcSEcCtD
Pamidronate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00143	CcSEcCtD
Pamidronate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00143	CcSEcCtD
Pamidronate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00142	CcSEcCtD
Pamidronate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00142	CcSEcCtD
Pamidronate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00131	0.0014	CcSEcCtD
Pamidronate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00131	0.0014	CcSEcCtD
Pamidronate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0013	0.0014	CcSEcCtD
Pamidronate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0014	CcSEcCtD
Pamidronate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00139	CcSEcCtD
Pamidronate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00139	CcSEcCtD
Pamidronate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00137	CcSEcCtD
Pamidronate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00137	CcSEcCtD
Pamidronate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00137	CcSEcCtD
Pamidronate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00137	CcSEcCtD
Pamidronate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00137	CcSEcCtD
Pamidronate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00136	CcSEcCtD
Pamidronate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00136	CcSEcCtD
Pamidronate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Pamidronate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Pamidronate—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Pamidronate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Pamidronate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Pamidronate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Pamidronate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00135	CcSEcCtD
Pamidronate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00135	CcSEcCtD
Pamidronate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00135	CcSEcCtD
Pamidronate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Pamidronate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Pamidronate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Pamidronate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Pamidronate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00133	CcSEcCtD
Pamidronate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Pamidronate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Pamidronate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Pamidronate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Pamidronate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00129	CcSEcCtD
Pamidronate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00128	CcSEcCtD
Pamidronate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00128	CcSEcCtD
Pamidronate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.00128	CcSEcCtD
Pamidronate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00128	CcSEcCtD
Pamidronate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00127	CcSEcCtD
Pamidronate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00127	CcSEcCtD
Pamidronate—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Pamidronate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Pamidronate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Pamidronate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Pamidronate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Pamidronate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Pamidronate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00124	CcSEcCtD
Pamidronate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00124	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00123	CcSEcCtD
Pamidronate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Pamidronate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Pamidronate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Pamidronate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Pamidronate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00122	CcSEcCtD
Pamidronate—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Pamidronate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Pamidronate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Pamidronate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Pamidronate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Pamidronate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.0012	CcSEcCtD
Pamidronate—Injury—Prednisone—chronic obstructive pulmonary disease	0.00112	0.0012	CcSEcCtD
Pamidronate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00111	0.0012	CcSEcCtD
Pamidronate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00119	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00119	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00119	CcSEcCtD
Pamidronate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00118	CcSEcCtD
Pamidronate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00118	CcSEcCtD
Pamidronate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00118	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00118	CcSEcCtD
Pamidronate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Pamidronate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Pamidronate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Pamidronate—Pain—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Pamidronate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Pamidronate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00116	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Pamidronate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Pamidronate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Pamidronate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00115	CcSEcCtD
Pamidronate—Pain—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00115	CcSEcCtD
Pamidronate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00115	CcSEcCtD
Pamidronate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Pamidronate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Pamidronate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Pamidronate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00113	CcSEcCtD
Pamidronate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00113	CcSEcCtD
Pamidronate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00113	CcSEcCtD
Pamidronate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00113	CcSEcCtD
Pamidronate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00113	CcSEcCtD
Pamidronate—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00113	CcSEcCtD
Pamidronate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00113	CcSEcCtD
Pamidronate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00112	CcSEcCtD
Pamidronate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00112	CcSEcCtD
Pamidronate—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00112	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Pamidronate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Pamidronate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00111	CcSEcCtD
Pamidronate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00111	CcSEcCtD
Pamidronate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00103	0.0011	CcSEcCtD
Pamidronate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Pamidronate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00109	CcSEcCtD
Pamidronate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00109	CcSEcCtD
Pamidronate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00109	CcSEcCtD
Pamidronate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00109	CcSEcCtD
Pamidronate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00108	CcSEcCtD
Pamidronate—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.001	0.00107	CcSEcCtD
Pamidronate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00107	CcSEcCtD
Pamidronate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000999	0.00107	CcSEcCtD
Pamidronate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000999	0.00107	CcSEcCtD
Pamidronate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000996	0.00107	CcSEcCtD
Pamidronate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000994	0.00107	CcSEcCtD
Pamidronate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000991	0.00106	CcSEcCtD
Pamidronate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000991	0.00106	CcSEcCtD
Pamidronate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000988	0.00106	CcSEcCtD
Pamidronate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000981	0.00105	CcSEcCtD
Pamidronate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000976	0.00105	CcSEcCtD
Pamidronate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.00103	CcSEcCtD
Pamidronate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.00103	CcSEcCtD
Pamidronate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000943	0.00101	CcSEcCtD
Pamidronate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000943	0.00101	CcSEcCtD
Pamidronate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000942	0.00101	CcSEcCtD
Pamidronate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000933	0.001	CcSEcCtD
Pamidronate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000924	0.000991	CcSEcCtD
Pamidronate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000918	0.000986	CcSEcCtD
Pamidronate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000918	0.000986	CcSEcCtD
Pamidronate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000906	0.000972	CcSEcCtD
Pamidronate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000906	0.000972	CcSEcCtD
Pamidronate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0009	0.000966	CcSEcCtD
Pamidronate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00089	0.000956	CcSEcCtD
Pamidronate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000887	0.000952	CcSEcCtD
Pamidronate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000876	0.00094	CcSEcCtD
Pamidronate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000876	0.00094	CcSEcCtD
Pamidronate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000867	0.000931	CcSEcCtD
Pamidronate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000863	0.000926	CcSEcCtD
Pamidronate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000858	0.000921	CcSEcCtD
Pamidronate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000855	0.000918	CcSEcCtD
Pamidronate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000849	0.000912	CcSEcCtD
Pamidronate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000846	0.000909	CcSEcCtD
Pamidronate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000846	0.000909	CcSEcCtD
Pamidronate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000829	0.00089	CcSEcCtD
Pamidronate—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000828	0.000889	CcSEcCtD
Pamidronate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000827	0.000888	CcSEcCtD
Pamidronate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000814	0.000874	CcSEcCtD
Pamidronate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000814	0.000874	CcSEcCtD
Pamidronate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.000866	CcSEcCtD
Pamidronate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000807	0.000866	CcSEcCtD
Pamidronate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000806	0.000865	CcSEcCtD
Pamidronate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000806	0.000865	CcSEcCtD
Pamidronate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000802	0.000861	CcSEcCtD
Pamidronate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000802	0.000861	CcSEcCtD
Pamidronate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000799	0.000858	CcSEcCtD
Pamidronate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000797	0.000856	CcSEcCtD
Pamidronate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000791	0.000848	CcSEcCtD
Pamidronate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00079	0.000848	CcSEcCtD
Pamidronate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000788	0.000846	CcSEcCtD
Pamidronate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000785	0.000843	CcSEcCtD
Pamidronate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000776	0.000833	CcSEcCtD
Pamidronate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000768	0.000825	CcSEcCtD
Pamidronate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000766	0.000822	CcSEcCtD
Pamidronate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.000818	CcSEcCtD
Pamidronate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000762	0.000818	CcSEcCtD
Pamidronate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000761	0.000817	CcSEcCtD
Pamidronate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00076	0.000816	CcSEcCtD
Pamidronate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.000816	CcSEcCtD
Pamidronate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000757	0.000813	CcSEcCtD
Pamidronate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000747	0.000801	CcSEcCtD
Pamidronate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000745	0.000799	CcSEcCtD
Pamidronate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000736	0.00079	CcSEcCtD
Pamidronate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000733	0.000787	CcSEcCtD
Pamidronate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.000771	CcSEcCtD
Pamidronate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000714	0.000767	CcSEcCtD
Pamidronate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000713	0.000765	CcSEcCtD
Pamidronate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000709	0.000761	CcSEcCtD
Pamidronate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000697	0.000748	CcSEcCtD
Pamidronate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000693	0.000744	CcSEcCtD
Pamidronate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000693	0.000744	CcSEcCtD
Pamidronate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000682	0.000732	CcSEcCtD
Pamidronate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000677	0.000726	CcSEcCtD
Pamidronate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00067	0.000719	CcSEcCtD
Pamidronate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000663	0.000711	CcSEcCtD
Pamidronate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000658	0.000706	CcSEcCtD
Pamidronate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000643	0.00069	CcSEcCtD
Pamidronate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00064	0.000687	CcSEcCtD
Pamidronate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000627	0.000673	CcSEcCtD
Pamidronate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000627	0.000672	CcSEcCtD
Pamidronate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000622	0.000668	CcSEcCtD
Pamidronate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000617	0.000662	CcSEcCtD
Pamidronate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000617	0.000662	CcSEcCtD
Pamidronate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000593	0.000636	CcSEcCtD
Pamidronate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000573	0.000615	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000571	0.000613	CcSEcCtD
Pamidronate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00057	0.000612	CcSEcCtD
Pamidronate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000567	0.000609	CcSEcCtD
Pamidronate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000564	0.000605	CcSEcCtD
Pamidronate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000557	0.000597	CcSEcCtD
Pamidronate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000554	0.000594	CcSEcCtD
Pamidronate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000543	0.000582	CcSEcCtD
Pamidronate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000535	0.000574	CcSEcCtD
Pamidronate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000533	0.000572	CcSEcCtD
Pamidronate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000564	CcSEcCtD
Pamidronate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000564	CcSEcCtD
Pamidronate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000524	0.000562	CcSEcCtD
Pamidronate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000519	0.000557	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000511	0.000548	CcSEcCtD
Pamidronate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000504	0.000541	CcSEcCtD
Pamidronate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000504	0.000541	CcSEcCtD
Pamidronate—Infection—Prednisone—chronic obstructive pulmonary disease	0.0005	0.000537	CcSEcCtD
Pamidronate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000496	0.000532	CcSEcCtD
Pamidronate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000494	0.00053	CcSEcCtD
Pamidronate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000528	CcSEcCtD
Pamidronate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000487	0.000523	CcSEcCtD
Pamidronate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00048	0.000515	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000459	0.000493	CcSEcCtD
Pamidronate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000458	0.000492	CcSEcCtD
Pamidronate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000456	0.000489	CcSEcCtD
Pamidronate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000452	0.000485	CcSEcCtD
Pamidronate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000443	0.000476	CcSEcCtD
Pamidronate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00047	CcSEcCtD
Pamidronate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000437	0.000469	CcSEcCtD
Pamidronate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000437	0.000469	CcSEcCtD
Pamidronate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000434	0.000466	CcSEcCtD
Pamidronate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000434	0.000466	CcSEcCtD
Pamidronate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000431	0.000462	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000415	0.000446	CcSEcCtD
Pamidronate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000412	0.000442	CcSEcCtD
Pamidronate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000412	0.000442	CcSEcCtD
Pamidronate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000398	0.000427	CcSEcCtD
Pamidronate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000398	0.000427	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000371	0.000398	CcSEcCtD
Pamidronate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000388	CcSEcCtD
Pamidronate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000356	0.000383	CcSEcCtD
Pamidronate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00037	CcSEcCtD
Pamidronate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000358	CcSEcCtD
Pamidronate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00032	0.000344	CcSEcCtD
Pamidronate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000341	CcSEcCtD
Pamidronate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000341	CcSEcCtD
Pamidronate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000339	CcSEcCtD
Pamidronate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000321	CcSEcCtD
